NOD1 can promote tumor progression by activating NF-κB signaling in ovarian cancer and esophageal squamous cell carcinoma (Nomoto et al., 2022b; Zhang and Wang, 2022). Here, NFKB1 is linked to esophageal squamous cell carcinoma.